Articles / Chronic COVID complaints
writer
Respiratory and Sleep Medicine Physician; Conjoint Professor, Monash University; School of Medicine and Public Health, University of Newcastle
0 hours
These are activities that expand general practice knowledge, skills and attitudes, related to your scope of practice.
0 hours
These are activities that require reflection on feedback about your work.
0 hours
These are activities that use your work data to ensure quality results.
These are activities that expand general practice knowledge, skills and attitudes, related to your scope of practice.
These are activities that require reflection on feedback about your work.
These are activities that use your work data to ensure quality results.
Picture: Javi Hoffens/Unsplash
Peter Wark, University of Newcastle
We’re now all too familiar with the common symptoms of COVID-19: a fever, dry cough and fatigue. Some people also experience aches and pains, a sore throat, and loss of taste or smell.
Sufferers with mild illness might expect to get better after a few weeks. But there’s mounting evidence this isn’t the case, and COVID-19 may leave a long-lasting impression on its victims – not just the most severely affected or the elderly and frail.
Tirzepatide Compared to Semaglutide for Treatment of Obesity – Latest Evidence
Genitourinary Syndrome of Menopause – Mythbusting for GPs
Dysmenorrhoea in Teens
Winter Virus Preparations
writer
Respiratory and Sleep Medicine Physician; Conjoint Professor, Monash University; School of Medicine and Public Health, University of Newcastle
Strongly agree
Slightly agree
Slightly disagree
Strongly disagree
Listen to expert interviews.
Click to open in a new tab
Browse the latest articles from Healthed.
Once you confirm you’ve read this article you can complete a Patient Case Review to earn 0.5 hours CPD in the Reviewing Performance (RP) category.
Select ‘Confirm & learn‘ when you have read this article in its entirety and you will be taken to begin your Patient Case Review.
Menopause and MHT
Multiple sclerosis vs antibody disease
Using SGLT2 to reduce cardiovascular death in T2D
Peripheral arterial disease